INGELHEIM, Germany, October 29, 2026 /3BL/ – Boehringer Ingelheim, today, on World Stroke Day, celebrates 10 years of the Angels Initiative and bringing better stroke care to more than 28 million patients worldwide, through education and connecting hospitals, emergency medical services and communities to improve awareness and healthcare.

  • Launched in 2016, Boehringer Ingelheim’s Angels Initiative helps hospitals worldwide to become “stroke-ready”, so that patients who have just suffered a stroke can be treated as quickly and effectively as possible.
  • Partners include World Stroke Organisation (WSO), European Stroke Organisation (ESO), Stroke Alliance for Europe (SAFE) and over 50 national stroke societies.
  • The initiative includes FAST Heroes, which was launched in 2019. This award-winning educational initiative aims to raise more awareness of stroke symptoms and the urgent need for quick action with school children, who very often spend time alone at home with their grandparents.
  • To date, 117 “Angels Regions” have been created, a holistic approach to connecting awareness and education to equipping healthcare professionals with best practice trainings to supporting hospitals become “stroke-ready” by implementing evidence-based approaches to acute stroke treatment, across entire communities and regions.

“We started the Angels Initiative in 2016 as a healthcare intervention dedicated to improving stroke care. Our aim is to give stroke patients the best chance possible, not only to survive, or lead a disability free life, but to be able to return to the life they once knew. We realized that enabling seamless collaboration is crucial to reducing the critical minutes needed, to mitigate the impact of a stroke.” (Jan Van der Merwe, co-founder and Global Project Lead of the Angels Initiative).

Why this Matters

  • Strokes impact millions of lives yearly, with one in four adults over 25 affected. Health consequences can be severe, causing disability and death, and straining families.
  • The Angels Initiative is part of Boehringer’s Sustainable Development for Generations framework and underlines the company’s dedication to closing gaps in healthcare systems.
  • By innovating stroke care systems, Boehringer highlights the global importance of enhanced stroke care, which can improve millions of lives each year.

Additional Information

Read more on Imagine – Boehringer Ingelheim’s sustainability story hub

AEG‘s LA Kings joined the Duarte family on Oct. 26 to make blankets for Angelenos experiencing homelessness, continuing a holiday tradition inspired by the late Chrissy Duarte and her commitment to helping others.

Held at Toyota Sports Performance Center in El Segundo, the annual event honors Chrissy, a former Kings staff member who was killed in the 2017 Route 91 Harvest festival shooting in Las Vegas. Before her death, Chrissy and her family made blankets each holiday season to provide warmth and comfort to people in need. In the years since, the Kings have joined the Duarte family in carrying that tradition forward.

This year, Kings staff and members of the Duarte family came together to hand-make 60 blankets, which will be donated to Better Angels on Nov. 21 to support Angelenos experiencing homelessness. Over 40 employees, family members and volunteers participated in the effort.

More than an annual day of service, the tradition has become a lasting tribute to Chrissy and the generosity she shared with those around her. Each year, her family and the Kings community turn remembrance into action, extending the impact of a simple tradition by providing warmth and care to neighbors in need.

Through the continued partnership between the Duarte family and the LA Kings, Chrissy’s spirit of service lives on, transforming a family tradition into an enduring legacy of compassion and community care.

Key Takeaways:

  • Psychosocial risk is no longer only an HR or wellbeing topic. Many regulators and standards bodies now expect it to be managed as an occupational health and safety risk.
  • In a growing number of countries, managing psychosocial hazards is now a legal requirement, and the requirements differ from country to country.
  • ISO 45003 is a guidance document, not a certifiable standard. It shows how to manage psychosocial hazards within an ISO 45001 occupational health and safety management system.
  • The draft revision of ISO 45001:2027 goes further, bringing psychosocial hazards and work-related well-being into the core standard.
  • The most effective controls change how work is designed and managed. Resilience training alone isn’t enough.
  • Organizational culture and Human and Organizational Performance (HOP) can help put a psychosocial program into practice

Many organizations approach workplace mental health primarily through employee benefits, offering resources such as employee assistance programs, resilience apps, or wellness initiatives. Others may give the issue little to no consideration at all. However, regulators and standards bodies are increasingly recognizing psychosocial risks as occupational health and safety hazards that can arise from how work is designed and managed. These risks belong within an organization’s safety management system.

Why Psychosocial Risk Has Moved Onto the EHS Agenda

The numbers have changed the conversation. In April 2026, the International Labour Organization (ILO) estimated that psychosocial risk factors at work account for more than 840,000 deaths a year and economic losses equivalent to approximately 1.37% of global GDP. The World Health Organization (WHO) estimates that depression and anxiety alone cost about 12 billion working days and US$1 trillion in lost productivity every year. These figures highlight the significant human and economic impacts of psychosocial risks alongside more traditionally recognized workplace injuries and illnesses.

Regulation has followed. Since December 2025, every Australian jurisdiction has had workplace health and safety regulations addressing psychological hazards, and some regulators now expect employers to use the hierarchy of controls rather than rely on training to protect workers. According to Safe Work Australia, the median serious mental-health claim costs about 3.7 times as much as the median across all claims and results in about 4.3 times as much time off work.

In the EU, employers have a general duty under the Framework Directive (89/391/EEC) to assess and manage all workplace risks, including psychosocial ones. Momentum is also building for more specific requirements. In October 2026, the European Parliament called on the Commission to assess the need for additional legislation on psychosocial risks, while EU-OSHA launched its 2026–2028 Healthy Workplaces campaign on mental health at work. In the U.S., NIOSH has called for a national regulatory or consensus standard on work-related psychosocial hazards.

For global organizations, a single voluntary wellbeing program is no longer enough. Obligations differ by country, and the expectation is shifting from “do you offer support?” to “how do you identify, assess, and control the hazard?”

What Is ISO 45003?

ISO 45003, published in 2021, is a guidance standard on managing psychological health and safety at work. It is designed to work within an ISO 45001 occupational health and safety (OH&S) management system. Although it is not independently certifiable, it provides guidance on applying the same risk-based approach used for physical hazards to psychosocial hazards.

ISO 45003 groups psychosocial hazards into three areas:

  • How work is organized: workload and pace, working hours, job control, role clarity, and how organizational change is managed.
  • Social factors: relationships, leadership, support, harassment, bullying, and workplace culture.
  • The work environment, equipment, and hazardous tasks: conditions that add strain, such as isolated work, fatigue, and exposure to traumatic events.

The impact goes beyond wellbeing. ISO 45003 notes that psychosocial hazards can increase exposure to other hazards through human error and time pressure, linking them directly to incident prevention.

Common Psychosocial Hazards in the Workplace

In practice, the most common hazards are familiar ones:

  • Sustained high workload or unrealistic deadlines
  • Fatigue from shift patterns, overtime, or long travel
  • Poorly managed organizational change
  • Unclear roles or conflicting expectations
  • Harassment or low-trust relationships
  • Remote or isolated work with limited support

Each of these hazards stems from how work is designed, resourced, and led. This makes an existing health and safety management system a useful framework for addressing these risks, rather than relying solely on a standalone wellbeing program.

How ISO 45003 Integrates with ISO 45001

If you have an ISO 45001 aligned or based management system, you already have the structure in place. ISO 45003 fits into the existing clauses without creating a parallel program:

  • Context and leadership (Clauses 4–5): Treat psychosocial risk as an organizational issue, include it in policy commitments, and make leaders visibly accountable.
  • Planning (Clause 6): Add psychosocial hazards to hazard identification and risk assessment, using the same methods and criteria.
  • Support and operation (Clauses 7–8): Build manager competence, set up confidential reporting channels, and apply controls through work design.
  • Performance evaluation and improvement (Clauses 9–10): Use surveys, absence data and incident learning as indicators, and bring them into management review.

The draft revision of ISO 45001, expected in 2027, expands hazard identification to explicitly include psychosocial hazards. It also introduces a definition of work-related well-being and adds new expectations on occupational health, return to work, and a supportive culture. Although the draft may still change, it signals a greater emphasis on psychosocial risk management. Organizations that begin aligning with ISO 45003 now may be better prepared for the revised standard when it is published.

Resilience Training Is the PPE of Psychosocial Risk

Guidance from NIOSH, WHO, and ISO emphasizes that the most effective controls change working conditions rather than relying solely on individual coping skills. Applied to psychosocial risk, the hierarchy of controls may look like this:

  • Redesign the work: Fix workload, staffing, scheduling and role ambiguity.
  • Improve how work is organized and led: Use fair processes, plan change properly, and train managers to recognize and respond to strain.
  • Administrative controls: Awareness training, clear reporting channels and policies.
  • Individual support: Employee assistance programs, counseling, and resilience training.

Individual support is valuable, but like personal protective equipment (PPE), it is the last line of defense. It doesn’t remove the hazard. When resilience training is the main control, employees are being asked to manage the effects of problems that may be rooted in how work is organized.

How HOP and Culture Make It Work

Writing a psychosocial program is the easy part. Putting it into practice depends on culture, leadership buy-in, and implementation strategy. This is where Human and Organizational Performance (HOP) can help, as its core principles align closely with ISO 45003:

  • Look at the system, not the individual. HOP treats error-likely conditions as a product of how work is set up. The same logic applies to conditions that contribute to workplace stress and strain.
  • Give workers a voice. ISO 45003 stresses worker participation at every stage. Learning teams are a practical way to understand workload, pressure, and workarounds from the people doing the work.
  • Learn instead of blame. When people aren’t penalized for mistakes or for raising concerns, they are more likely to report issues early. Culture and psychological safety surveys can provide measurable indicators to inform psychosocial risk assessments.

What Organizations Can Do Now

The following foundational steps can help organizations move from offering individual support to systematically managing psychosocial hazards:

  1. Add psychosocial hazards to your existing risk register and assess them with the same criteria you use for physical hazards.
  2. Run a culture or psychosocial survey to set a baseline and track leading indicators.
  3. Equip managers to recognize and respond to strain. According to Gallup’s State of the Global Workplace report, employees with poor managers are 60% more likely to report daily stress. With manager engagement also declining, organizations should ensure managers have the skills, time, and clear escalation routes needed to recognize and address psychosocial risks.
  4. Address the sources of strain first. Workload, staffing, scheduling, and role clarity can contribute significantly to psychosocial risk, so start your controls there.
  5. Bring psychosocial factors into incident investigations and management review.
  6. Map your country-specific obligations if you operate internationally and build a global baseline with local addenda.

Bringing Psychosocial Risk Management Together

Most organizations already have some of the pieces in place, such as an ISO 45001 management system (or 45001 aligned), a wellbeing program, or an annual culture survey. What’s often missing is the connection between them. ISO 45003 provides a framework for bringing these elements together, while HOP principles and organizational culture help support implementation.

Antea Group helps organizations bring these elements into a single management-system approach by assessing current psychosocial risk, designing controls that fit the way work actually gets done, and building processes that adapt as organizations and their global regulatory obligations change. The goal is to move beyond asking whether support is available to demonstrating how psychosocial hazards are identified, assessed, and controlled.

Need help integrating psychosocial risk into your existing health and safety management system? Contact our team to discuss your organization’s current approach and opportunities for improvement.

PROVIDENCE, R.I.–(BUSINESS WIRE)–Bally’s Corporation (NYSE: BALY) today commented on the Federal Court of Australia’s decision in the Australian Transaction Reports and Analysis Centre (“AUSTRAC”) proceedings against subsidiaries of The Star Entertainment Group Limited (“The Star”) related to historical violations of the Anti-Money Laundering and Counter-Terrorism Financing Act 2006. The Federal Court imposed a penalty of $260 million, payable in four installments over 19 months. The proceedi

NAARDEN, Netherlands & WALTHAM, Mass. & BARCELONA, Spain–(BUSINESS WIRE)– #HD–Prilenia Therapeutics B.V. and Ferreri today announced the publication online, on October 22, 2026, of a new manuscript, in Neurology®, the medical journal of the American Academy of Neurology, presenting a post hoc analysis providing Phase 3 clinical trial evidence of the association between exposure to antidopaminergic medications (ADMs) and clinical outcome measures  in Huntington’s disease (HD) . The manuscript, “Ant

CEO Jonathan Cohen to Discuss Laboratory Franchise Model, 2027 Licensing Plans, Potential Acquisitions, FDA Strategy, and Firefighter Cancer Screening Initiatives

Webinar to Be Held Wednesday, November 4, 2026 at 12:00 p.m. Eastern Time; Registration Is Now Open

GAITHERSBURG, Md., Oct. 29, 2026 (GLOBE NEWSWIRE) — 20/20 BioLabs, Inc. (Nasdaq: AIDX) (“20/20 BioLabs” or the “Company”), an early market entrant in AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases, today announced that it will host an investor webinar on Wednesday, November 4, 2026, at 12:00 p.m. Eastern time.

Jonathan Cohen, President and Chief Executive Officer of 20/20 BioLabs, will discuss the Company’s plans to expand the commercial reach of OneTest™ through its laboratory franchise and licensing strategies, as well as potential acquisitions, U.S. Food and Drug Administration (“FDA”) planning, and new Maryland legislation expected to expand state-funded firefighter cancer screening.

To access the webinar, please use the following information:

Date: Wednesday, November 4, 2026
Time: 12:00 p.m. Eastern time (9:00 a.m. Pacific time)
Webcast: Please click here to register.

During the webinar, management expects to address the following topics:

  • OneTest™ Franchise Program: Updates on preliminary interest from regional laboratories, the proposed royalty-based structure, and how the franchise model could expand distribution through partner-funded customer acquisition while the Company retains ownership of its technology and longitudinal biomarker data;
  • 2027 Licensing Plans: The Company’s plans to license its patented protein tumor marker approach to multi-cancer early detection (“MCED”) testing to clinical laboratories in the United States and internationally;
  • Roll-Up Acquisition Strategy: Potential acquisitions of complementary businesses in health, wellness, early cancer detection, longevity testing, and nutrition, and how these businesses could benefit from access to the OneTest™ platform and shared public company infrastructure;
  • FDA and Medicare Strategy: The Company’s FDA planning for OneTest™ for Cancer, including management’s perspective on the September 23, 2026 FDA advisory committee meeting concerning GRAIL’s Galleri® MCED blood test, and its goal of achieving Medicare reimbursement for MCED by the end of 2028;
  • Firefighter Cancer Screening: Potential Maryland legislation to expand the state’s existing firefighter cancer screening grant program, under which 18 groups of Maryland fire departments were notified in March 2026 of awards totaling more than $520,000 to procure and administer OneTest™; and
  • A live question-and-answer session with management.

“Our goal is to expand the reach of OneTest by working with established laboratories, licensing our technology, and pursuing acquisitions that could bring additional customers onto our testing platform,” said Jonathan Cohen, President and Chief Executive Officer of 20/20 BioLabs. “On November 4, I look forward to discussing how these initiatives could support our growth in 2027, along with our FDA planning and the opportunities we see to expand state-funded firefighter cancer screening programs.”

The November 4 webinar is part of the Company’s monthly investor webinar series, held on the first Wednesday of each month at 12:00 p.m. Eastern time. Investors and other interested parties are encouraged to submit questions in advance to AIDX@mzgroup.us. A replay will be made available through the Company’s investor relations website following the event.

As part of its commitment to expanding access to early cancer detection, 20/20 BioLabs will provide webinar attendees with a promotional discount code for OneTest™ at the conclusion of the event. The offer will be available to all attendees, regardless of shareholder status.

Any potential franchise, licensing, or acquisition transaction would be subject to the negotiation and execution of definitive agreements and other customary conditions. There can be no assurance that any such transaction will be completed or generate revenue, or that the proposed Maryland legislation will be introduced or enacted. The Company’s regulatory and reimbursement objectives are also subject to uncertainty.

Additional detail on the Company’s business, results of operations, and risk factors is available in its filings with the U.S. Securities and Exchange Commission, including its most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q. The webinar will not include a discussion of the Company’s third quarter 2026 financial results and is not expected to include the disclosure of any material non-public information.

About 20/20 BioLabs

20/20 BioLabs, Inc. (Nasdaq: AIDX) develops and commercializes AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases. The Company offers two families of lab tests under the OneTest brand. OneTest™ for Cancer is a multi-cancer early detection blood test and OneTest™ for Longevity measures inflammatory biomarkers and is commercially available. OneTest’s tests are designed to be affordable and accessible and can be conveniently utilized at home using new, upper-arm capillary collection devices as an alternative to traditional venipuncture. Tests are run in the Company’s College of American Pathologists (CAP) accredited, Clinical Laboratory Improvement Amendments (CLIA) licensed laboratory in Gaithersburg, Maryland.
For more information visit https://2020biolabs.com.

Forward-Looking Statements

Certain statements in this release are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that it believes may affect its financial condition, results of operations, business strategy, regulatory strategy, reimbursement strategy, growth strategy, acquisition strategy, and financial needs. Forward-looking statements can be identified by words such as “may,” “could,” “will,” “should,” “would,” “expect,” “plan,” “intend,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “project,” “continue,” or the negative of these terms or other comparable expressions.

Forward-looking statements in this release include, but are not limited to, statements regarding the Company’s planned investor webinar and the topics management expects to address. Actual results may differ materially from those expressed or implied by such forward-looking statements as a result of various factors, including the risks described in the Company’s filings with the U.S. Securities and Exchange Commission.

There can be no assurance that the Company will complete any strategic transaction on any particular timeline, or at all. The Company undertakes no obligation to publicly update or revise any forward-looking statements to reflect events or circumstances that occur after the date of this release or to reflect the occurrence of unanticipated events, except as required by applicable law.

Investor Relations
Chris Tyson
MZ Group
Direct: 949-491-8235
AIDX@mzgroup.us

AMSTERDAM–(BUSINESS WIRE)– #insurance–AM Best has affirmed the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Rating of “a” (Excellent) of Eni Insurance S.p.A. (EIS) (Italy), a captive of Eni S.p.A. (Eni), a multinational energy company based in Italy. The outlook of these Credit Ratings (ratings) is stable.The ratings reflect EIS’ balance sheet strength, which AM Best assesses as very strong, as well as its strong operating performance, neutral business profile and appropriate

NEW YORK–(BUSINESS WIRE)–Bankrate, a leading consumer advocate for home lending information and financial services, today released new Bankrate Star Ratings – the largest, most comprehensive and data-driven review of the mortgage lending industry. Bankrate Star Ratings cover nearly 2,000 lenders and span 23.5 million mortgages, originating between 2022-2025. This first-of-its-kind rating system is designed to help consumers compare and identify the best lenders across the home lending industr

COLUMBIA, Mo., Oct. 29, 2026 (GLOBE NEWSWIRE) — EquipmentShare.com Inc (NASDAQ: EQPT) (“EquipmentShare”), a leader in connected jobsite technology and one of the largest construction equipment rental providers in the United States, today announced that it will participate in Baird’s 2026 Global Industrial Conference on Wednesday, November 11th. The conference will include a fireside chat by Jabbok Schlacks, Chief Executive Officer and Founder of EquipmentShare.

Mr. Schlacks’ fireside chat is scheduled to start at 7:20a.m. CT and will be accessible via a live webcast at the link below:
https://event.summitcast.com/view/8hgfu2da8CspZvFv8aZFfm/A5U9QedeZJ8Y2XLy8JqYBD

About EquipmentShare
Founded in 2015 and headquartered in Columbia, Missouri, EquipmentShare (NASDAQ: EQPT) is a nationwide construction technology and equipment solutions provider dedicated to transforming the construction industry through innovative tools, platforms and data-driven insights. By empowering contractors, builders and equipment owners with its proprietary technology, T3®, EquipmentShare aims to drive productivity, efficiency and collaboration across the construction sector. With a comprehensive suite of solutions that includes a fleet management platform, telematics devices and a best-in-class equipment rental marketplace, EquipmentShare continues to lead the industry in building the future of construction. For more information, visit www.equipmentshare.com.

Investor Inquiries:
Rhett Butler
ir@equipmentshare.com

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.